SUN PHARMACEUTICAL IND L Share Price, Financial Results, Charts & Analysis

SUN PHARMACEUTICAL IND L (SUNPHARMA)

NSE: ₹1,780.10

BSE: ₹1,779.35

Corporate Announcements

Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015

As attached

2026-06-14 11:44:20

Intimation Of Record Date For The Purpose Of Final Dividend For FY 2025-26

Intimation of Record Date

2026-06-12 13:28:40

Corporate Action-Board to consider Dividend

Intimation of Record Date for Final Dividend

2026-06-11 22:56:47

Intimation Of 34Th Annual General Meeting And Record Date For Final Dividend And Connected Matters

Intimation of 34th AGM and Record Date for Final Dividend

2026-06-11 14:31:46

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript for 22 May 2026 Analyst Meet

2026-05-29 20:08:05

Particulars	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue from Operations	5,948.22	5,096.21	5,073.75	5,639.14	5,127.71	6,191.81	7,185.74	5,601.96	4,548.11	5,687.77	4,923.88	5,741.13
YOY Revenue Growth %	48.45%	3.31%	-4%	21.38%	-13.79%	21.5%	41.63%	-0.66%	-11.3%	-8.14%	-31.48%	2.48%
Other Income	120.30	106.54	76.80	118.88	86.30	68.39	132.00	103.69	72.79	179.90	62.93	140.17
Total Income	6,068.52	5,202.75	5,150.55	5,758.02	5,214.01	6,260.20	7,317.74	5,705.65	4,620.90	5,867.67	4,986.81	5,881.30
Total Expenses +	3,457.85	4,296.23	4,329.27	4,356.24	4,318.37	4,995.27	4,705.66	4,233.13	3,949.15	4,511.87	4,137.80	4,363.32
Cost of Materials Consumed	1,189.86	1,066.90	1,121.64	1,055.87	1,225.01	1,162.73	1,329.70	1,067.24	996.19	1,160.49	1,228.66	1,239.74
Employee Benefit Expense	529.05	600.41	590.13	575.97	662.19	651.68	648.91	715.00	728.77	739.62	703.99	830.93
Other Expenses	1,738.94	1,725.23	1,646.65	1,854.24	1,684.66	2,175.16	1,894.04	1,504.40	1,285.99	1,684.75	1,695.72	1,450.43
Operating Profit	2,490.37	799.98	744.48	1,282.90	809.34	1,196.54	2,480.08	1,368.83	598.96	1,175.90	786.08	1,377.81
OPM %	41.9%	15.7%	14.7%	22.7%	15.8%	19.3%	34.5%	24.4%	13.2%	20.7%	16%	24%
Profit Before Tax +	-1,030.27	906.52	751.47	1,401.78	895.64	1,264.93	2,612.08	1,184.88	671.75	1,097.10	849.01	1,486.45
Tax Expense	-9.45	17.89	30.16	534.18	32.35	83.88	611.62	431.35	107.53	391.66	240.31	371.31
Tax %	-	2%	4%	38.1%	3.6%	6.6%	23.4%	36.4%	16%	35.7%	28.3%	25%
Profit After Tax	-1,020.82	888.63	721.31	867.60	863.29	1,181.05	2,000.46	753.53	564.22	705.44	608.70	1,115.14
EPS (Basic)	-4.30	3.70	3.00	3.60	3.60	4.90	8.30	3.10	2.40	2.90	2.50	4.60

Particulars

Mar 2023

Sep 2023

Dec 2023

Mar 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Revenue from Operations

5,948.22

5,096.21

5,073.75

5,639.14

5,127.71

6,191.81

7,185.74

5,601.96

4,548.11

5,687.77

4,923.88

5,741.13

YOY Revenue Growth %

48.45%

3.31%

-4%

21.38%

-13.79%

21.5%

41.63%

-0.66%

-11.3%

-8.14%

-31.48%

2.48%

Other Income

120.30

106.54

76.80

118.88

86.30

68.39

132.00

103.69

72.79

179.90

62.93

140.17

Total Income

6,068.52

5,202.75

5,150.55

5,758.02

5,214.01

6,260.20

7,317.74

5,705.65

4,620.90

5,867.67

4,986.81

5,881.30

Total Expenses +

3,457.85

4,296.23

4,329.27

4,356.24

4,318.37

4,995.27

4,705.66

4,233.13

3,949.15

4,511.87

4,137.80

4,363.32

Cost of Materials Consumed

1,189.86

1,066.90

1,121.64

1,055.87

1,225.01

1,162.73

1,329.70

1,067.24

996.19

1,160.49

1,228.66

1,239.74

Employee Benefit Expense

529.05

600.41

590.13

575.97

662.19

651.68

648.91

715.00

728.77

739.62

703.99

830.93

Other Expenses

1,738.94

1,725.23

1,646.65

1,854.24

1,684.66

2,175.16

1,894.04

1,504.40

1,285.99

1,684.75

1,695.72

1,450.43

Operating Profit

2,490.37

799.98

744.48

1,282.90

809.34

1,196.54

2,480.08

1,368.83

598.96

1,175.90

786.08

1,377.81

OPM %

41.9%

15.7%

14.7%

22.7%

15.8%

19.3%

34.5%

24.4%

13.2%

20.7%

16%

24%

Profit Before Tax +

-1,030.27

906.52

751.47

1,401.78

895.64

1,264.93

2,612.08

1,184.88

671.75

1,097.10

849.01

1,486.45

Tax Expense

-9.45

17.89

30.16

534.18

32.35

83.88

611.62

431.35

107.53

391.66

240.31

371.31

Tax %

38.1%

3.6%

6.6%

23.4%

36.4%

16%

35.7%

28.3%

25%

Profit After Tax

-1,020.82

888.63

721.31

867.60

863.29

1,181.05

2,000.46

753.53

564.22

705.44

608.70

1,115.14

EPS (Basic)

-4.30

3.70

3.00

3.60

4.90

8.30

3.10

2.40

2.90

2.50

4.60

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue from Operations	20,754.64	23,003.33	20,275.17	20,812.14	15,585.98	12,803.21	12,531.93
YOY Revenue Growth %	-9.78%	13.46%	-2.58%	33.53%	21.73%	2.16%	-
Other Income	419.33	369.43	465.76	279.03	957.92	150.22	1,510.92
Total Income	21,173.97	23,372.76	20,740.93	21,091.17	16,543.90	12,953.43	14,042.85
Total Expenses +	16,833.51	18,342.19	17,072.26	13,450.75	14,416.51	10,711.00	10,789.85
Cost of Materials Consumed	4,383.27	4,690.67	4,429.38	5,165.63	4,584.97	3,809.11	3,201.71
Employee Benefit Expense	2,911.30	2,608.26	2,373.95	2,156.95	2,000.78	1,798.45	1,702.77
Other Expenses	6,193.69	7,621.42	6,709.50	6,128.17	5,027.29	3,274.86	3,549.79
Operating Profit	3,921.13	4,661.14	3,202.91	7,361.39	1,169.47	2,092.21	1,742.08
OPM %	18.9%	20.3%	15.8%	35.4%	7.5%	16.3%	13.9%
Profit Before Exceptional	4,340.46	5,030.57	3,668.67	4,678.84	2,127.39	2,242.43	3,253.00
Exceptional Items	-546.34	0.00	-219.02	-2,937.79	-1,820.53	-89.56	0.00
Profit Before Tax +	3,794.12	5,030.57	3,449.65	1,741.05	306.86	2,152.87	3,253.00
Tax Expense	1,170.70	747.95	591.47	50.33	406.85	13.17	41.86
Tax %	30.9%	14.9%	17.1%	2.9%	132.6%	0.6%	1.3%
Profit After Tax	2,623.42	4,282.62	2,858.18	1,690.72	-99.99	2,139.70	3,211.14
EPS (Basic)	10.90	17.80	11.90	7.00	-0.40	8.92	13.38

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Revenue from Operations

20,754.64

23,003.33

20,275.17

20,812.14

15,585.98

12,803.21

12,531.93

YOY Revenue Growth %

-9.78%

13.46%

-2.58%

33.53%

21.73%

2.16%

Other Income

419.33

369.43

465.76

279.03

957.92

150.22

1,510.92

Total Income

21,173.97

23,372.76

20,740.93

21,091.17

16,543.90

12,953.43

14,042.85

Total Expenses +

16,833.51

18,342.19

17,072.26

13,450.75

14,416.51

10,711.00

10,789.85

Cost of Materials Consumed

4,383.27

4,690.67

4,429.38

5,165.63

4,584.97

3,809.11

3,201.71

Employee Benefit Expense

2,911.30

2,608.26

2,373.95

2,156.95

2,000.78

1,798.45

1,702.77

Other Expenses

6,193.69

7,621.42

6,709.50

6,128.17

5,027.29

3,274.86

3,549.79

Operating Profit

3,921.13

4,661.14

3,202.91

7,361.39

1,169.47

2,092.21

1,742.08

OPM %

18.9%

20.3%

15.8%

35.4%

7.5%

16.3%

13.9%

Profit Before Exceptional

4,340.46

5,030.57

3,668.67

4,678.84

2,127.39

2,242.43

3,253.00

Exceptional Items

-546.34

0.00

-219.02

-2,937.79

-1,820.53

-89.56

0.00

Profit Before Tax +

3,794.12

5,030.57

3,449.65

1,741.05

306.86

2,152.87

3,253.00

Tax Expense

1,170.70

747.95

591.47

50.33

406.85

13.17

41.86

Tax %

30.9%

14.9%

17.1%

2.9%

132.6%

0.6%

1.3%

Profit After Tax

2,623.42

4,282.62

2,858.18

1,690.72

-99.99

2,139.70

3,211.14

EPS (Basic)

10.90

17.80

11.90

7.00

-0.40

8.92

13.38

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
ASSETS
Non-Current Assets +	26,349.92	24,521.06	26,110.38	24,522.34	31,061.73	26,932.49	26,469.21
Property, Plant & Equipment	5,145.40	4,345.05	4,539.14	4,733.25	4,969.57	4,873.98	4,910.31
Capital Work in Progress	652.16	563.39	388.24	328.87	358.94	442.85	384.35
Non-Current Investments	12,951.56	12,410.11	12,429.97	12,416.14	15.42	9.57	8.54
Goodwill	120.90	120.80	120.80	120.80	120.80	120.80	120.80
Other Intangible Assets	2,346.79	2,522.67	3,076.80	3,857.62	4,622.41	249.58	197.63
Current Assets +	16,678.72	18,721.98	14,912.54	16,443.75	9,703.75	12,066.34	11,941.12
Inventories	4,302.27	3,787.49	3,423.62	3,989.19	3,403.74	3,165.72	2,633.67
Trade Receivables	10,166.23	11,701.43	8,834.16	7,125.02	4,245.16	6,370.62	6,168.13
Cash and Cash Equivalents	417.84	492.02	326.46	410.28	419.53	222.34	220.50
Current Investments	0.00	0.00	0.00	200.26	193.04	31.00	395.07
LIABILITIES & EQUITY
Total Equity	22,370.76	24,339.85	23,694.40	0.00	24,587.95	25,040.16	24,396.22
Equity Share Capital	239.93	239.93	239.93	239.93	239.93	239.93	239.93
Other Equity	22,130.83	24,099.92	23,454.47	23,508.43	24,348.02	24,800.23	24,156.29
Non-Current Liabilities	14,185.54	785.07	12,925.25	8,873.07	6,071.70	5,615.12	2,810.37
Current Liabilities	6,503.24	18,148.53	4,444.51	8,365.44	10,105.83	8,343.55	11,203.74
Total Liabilities	20,688.78	18,933.60	17,370.39	17,239.13	16,177.53	13,958.67	14,014.11

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

ASSETS

Non-Current Assets +

26,349.92

24,521.06

26,110.38

24,522.34

31,061.73

26,932.49

26,469.21

Property, Plant & Equipment

5,145.40

4,345.05

4,539.14

4,733.25

4,969.57

4,873.98

4,910.31

Capital Work in Progress

652.16

563.39

388.24

328.87

358.94

442.85

384.35

Non-Current Investments

12,951.56

12,410.11

12,429.97

12,416.14

15.42

9.57

8.54

Goodwill

120.90

120.80

Other Intangible Assets

2,346.79

2,522.67

3,076.80

3,857.62

4,622.41

249.58

197.63

Current Assets +

16,678.72

18,721.98

14,912.54

16,443.75

9,703.75

12,066.34

11,941.12

Inventories

4,302.27

3,787.49

3,423.62

3,989.19

3,403.74

3,165.72

2,633.67

Trade Receivables

10,166.23

11,701.43

8,834.16

7,125.02

4,245.16

6,370.62

6,168.13

Cash and Cash Equivalents

417.84

492.02

326.46

410.28

419.53

222.34

220.50

Current Investments

0.00

200.26

193.04

31.00

395.07

LIABILITIES & EQUITY

Total Equity

22,370.76

24,339.85

23,694.40

0.00

24,587.95

25,040.16

24,396.22

Equity Share Capital

239.93

Other Equity

22,130.83

24,099.92

23,454.47

23,508.43

24,348.02

24,800.23

24,156.29

Non-Current Liabilities

14,185.54

785.07

12,925.25

8,873.07

6,071.70

5,615.12

2,810.37

Current Liabilities

6,503.24

18,148.53

4,444.51

8,365.44

10,105.83

8,343.55

11,203.74

Total Liabilities

20,688.78

18,933.60

17,370.39

17,239.13

16,177.53

13,958.67

14,014.11

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Cash from Operating Activities	6,500.87	4,198.77	-292.42	507.08	7,636.36	1,737.25
Cash from Investing Activities	-1,380.95	-209.56	-262.91	-705.17	-2,702.10	-601.80
Cash from Financing Activities	-5,230.18	-3,831.18	473.95	169.31	-4,870.85	-1,126.29
Net Increase/Decrease in Cash	-74.73	165.56	-83.82	-9.25	68.47	1.84

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Cash from Operating Activities

6,500.87

4,198.77

-292.42

507.08

7,636.36

1,737.25

0.00

Cash from Investing Activities

-1,380.95

-209.56

-262.91

-705.17

-2,702.10

-601.80

0.00

Cash from Financing Activities

-5,230.18

-3,831.18

473.95

169.31

-4,870.85

-1,126.29

0.00

Net Increase/Decrease in Cash

-74.73

165.56

-83.82

-9.25

68.47

1.84

0.00

SUN PHARMACEUTICAL IND L (SUNPHARMA)

Stock Performance

Corporate Announcements

Quarterly Financials

Yearly Financial Results

Balance Sheet

Cash Flow Statement